Showing 581 - 600 results of 107,538 for search '(( 16 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.36s Refine Results
  1. 581
  2. 582
  3. 583

    Sinupret is a robust activator of CFTR-mediated and calcium-activated Cl<sup>-</sup> secretion. by Shaoyan Zhang (363713)

    Published 2014
    “…Sinupret significantly increased ΔI<sub>SC</sub> (in µA/cm<sup>2</sup>)when compared to controls in both WT (20.7+/−0.9 vs. 5.6+/−0.9, p<0.05) and CFTR<sup>−/−</sup> MNSE (ΔI<sub>SC</sub> in µA/cm<sup>2</sup>, 10.1+/−1.0 vs. 0.9+/−0.3, p<0.05). …”
  4. 584

    PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression. by Emmanouella Tsirimonaki (490707)

    Published 2013
    “…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”
  5. 585
  6. 586
  7. 587

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
  8. 588
  9. 589
  10. 590
  11. 591
  12. 592
  13. 593
  14. 594

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  15. 595

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  16. 596

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  17. 597
  18. 598
  19. 599
  20. 600